{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:36:57Z","timestamp":1786117017010,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100015731","name":"Bayer Yakuhin","doi-asserted-by":"publisher","award":["Bayer Yakuhin"],"award-info":[{"award-number":["Bayer Yakuhin"]}],"id":[{"id":"10.13039\/100015731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"DOI":"10.1186\/s13550-026-01463-3","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:15:59Z","timestamp":1780416959000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["GWAS from a multicenter prospective study of radium-223 in bone-metastatic castration-resistant prostate cancer"],"prefix":"10.1186","volume":"16","author":[{"given":"Tokiyoshi","family":"Tanegashima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3306-4858","authenticated-orcid":false,"given":"Masaki","family":"Shiota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Tatarano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Kamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Igawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Masumori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotsugu","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Kamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyoshi","family":"Higashijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Mitsunari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroji","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Sumiyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Isoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kousei","family":"Ishigami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Eto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"issue":"3","key":"1463_CR1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1056\/NEJMoa1213755","volume":"369","author":"C Parker","year":"2013","unstructured":"Parker C, Nilsson S, Heinrich D, et al. Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med. 2013;369(3):213\u201323. https:\/\/doi.org\/10.1056\/NEJMoa1213755.","journal-title":"N Engl J Med"},{"issue":"22","key":"1463_CR2","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1056\/NEJMoa1911440","volume":"382","author":"J de Bono","year":"2020","unstructured":"de Bono J, Mateo J, Fizazi K, et al. Olaparib for Metastatic Castration-Resistant Prostate Cancer. N Engl J Med. 2020;382(22):2091\u2013102. https:\/\/doi.org\/10.1056\/NEJMoa1911440.","journal-title":"N Engl J Med"},{"key":"1463_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ejca.2021.09.029","volume":"159","author":"M Aldea","year":"2021","unstructured":"Aldea M, Lam L, Orillard E, et al. Cabazitaxel activity in men with metastatic castration-resistant prostate cancer with and without DNA damage repair defects. Eur J Cancer. 2021;159:87\u201397. https:\/\/doi.org\/10.1016\/j.ejca.2021.09.029.","journal-title":"Eur J Cancer"},{"issue":"2","key":"1463_CR4","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.eururo.2018.09.040","volume":"76","author":"P Isaacsson Velho","year":"2019","unstructured":"Isaacsson Velho P, Qazi F, Hassan S, et al. Efficacy of Radium-223 in Bone-metastatic Castration-resistant Prostate Cancer with and Without Homologous Repair Gene Defects. Eur Urol. 2019;76(2):170\u20136. https:\/\/doi.org\/10.1016\/j.eururo.2018.09.040.","journal-title":"Eur Urol"},{"key":"1463_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ejca.2020.05.001","volume":"136","author":"MJ van der Doelen","year":"2020","unstructured":"van der Doelen MJ, Isaacsson Velho P, Slootbeek PHJ, et al. Impact of DNA damage repair defects on response to radium-223 and overall survival in metastatic castration-resistant prostate cancer. Eur J Cancer. 2020;136:16\u201324. https:\/\/doi.org\/10.1016\/j.ejca.2020.05.001.","journal-title":"Eur J Cancer"},{"issue":"1","key":"1463_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s44276-024-00093-3","volume":"2","author":"M Shiota","year":"2024","unstructured":"Shiota M, Nemoto S, Ikegami R, et al. Predictive model of castration resistance in advanced prostate cancer by machine learning using genetic and clinical data: KYUCOG-1401-A study. BJC Rep. 2024;2(1):69. https:\/\/doi.org\/10.1038\/s44276-024-00093-3.","journal-title":"BJC Rep"},{"issue":"2","key":"1463_CR7","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/cas.70293","volume":"117","author":"M Shiota","year":"2026","unstructured":"Shiota M, Tatarano S, Kamba T, et al. Effectiveness and Safety of Radium-223 for Bone-Metastatic Castration-Resistant Prostate Cancer: The KYUCOG-1901 Study. Cancer Sci. 2026;117(2):501\u201310. https:\/\/doi.org\/10.1111\/cas.70293.","journal-title":"Cancer Sci"},{"issue":"10","key":"1463_CR8","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/jhg.2015.68","volume":"60","author":"Y Kawai","year":"2015","unstructured":"Kawai Y, Mimori T, Kojima K, et al. Japonica array: improved genotype imputation by designing a population-specific SNP array with 1070 Japanese individuals. J Hum Genet. 2015;60(10):581\u20137. https:\/\/doi.org\/10.1038\/jhg.2015.68.","journal-title":"J Hum Genet"},{"issue":"7","key":"1463_CR9","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s00262-020-02533-8","volume":"69","author":"M Shiota","year":"2020","unstructured":"Shiota M, Fujimoto N, Yamamoto Y, et al. Genome-wide association study of genetic variations associated with treatment failure after intravesical bacillus Calmette-Gu\u00e9rin therapy for non-muscle invasive bladder cancer. Cancer Immunol Immunother. 2020;69(7):1155\u201363. https:\/\/doi.org\/10.1007\/s00262-020-02533-8.","journal-title":"Cancer Immunol Immunother"},{"issue":"6","key":"1463_CR10","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1007\/s00262-023-03367-w","volume":"72","author":"M Shiota","year":"2023","unstructured":"Shiota M, Miyake H, Takahashi M, et al. Effect of genetic polymorphisms on outcomes following nivolumab for advanced renal cell carcinoma in the SNiP-RCC trial. Cancer Immunol Immunother. 2023;72(6):1903\u201315. https:\/\/doi.org\/10.1007\/s00262-023-03367-w.","journal-title":"Cancer Immunol Immunother"},{"issue":"7","key":"1463_CR11","doi-asserted-by":"publisher","first-page":"e230044","DOI":"10.1530\/ERC-23-0044","volume":"30","author":"M Shiota","year":"2023","unstructured":"Shiota M, Tatarano S, Kamoto T, et al. Genome-wide association studies in advanced prostate cancer: KYUCOG-1401-A study. Endocr Relat Cancer. 2023;30(7):e230044. https:\/\/doi.org\/10.1530\/ERC-23-0044.","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"1463_CR12","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559\u201375. https:\/\/doi.org\/10.1086\/519795.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"1463_CR13","doi-asserted-by":"publisher","first-page":"e1608","DOI":"10.1002\/mpr.1608","volume":"27","author":"AT Marees","year":"2018","unstructured":"Marees AT, de Kluiver H, Stringer S, et al. A tutorial on conducting genome-wide association studies: Quality control and statistical analysis. Int J Methods Psychiatr Res. 2018;27(2):e1608. https:\/\/doi.org\/10.1002\/mpr.1608.","journal-title":"Int J Methods Psychiatr Res"},{"issue":"5","key":"1463_CR14","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/nprot.2014.071","volume":"9","author":"TW Winkler","year":"2014","unstructured":"Winkler TW, Day FR, Croteau-Chonka DC, et al. Quality control and conduct of genome-wide association meta-analyses. Nat Protoc. 2014;9(5):1192\u2013212. https:\/\/doi.org\/10.1038\/nprot.2014.071.","journal-title":"Nat Protoc"},{"issue":"8","key":"1463_CR15","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/ng.3020","volume":"46","author":"L Fachal","year":"2014","unstructured":"Fachal L, G\u00f3mez-Caama\u00f1o A, Barnett GC, et al. A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1. Nat Genet. 2014;46(8):891\u20134. https:\/\/doi.org\/10.1038\/ng.3020.","journal-title":"Nat Genet"},{"issue":"6509","key":"1463_CR16","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.aaz1776","volume":"369","author":"GTEx Consortium","year":"2020","unstructured":"GTEx Consortium. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science. 2020;369(6509):1318\u201330. https:\/\/doi.org\/10.1126\/science.aaz1776.","journal-title":"Science"},{"issue":"12","key":"1463_CR17","doi-asserted-by":"publisher","first-page":"e46255","DOI":"10.15252\/embr.201846255","volume":"19","author":"S Oki","year":"2018","unstructured":"Oki S, Ohta T, Shioi G, et al. ChIP-Atlas: a data-mining suite powered by full integration of public ChIP-seq data. EMBO Rep. 2018;19(12):e46255. https:\/\/doi.org\/10.15252\/embr.201846255.","journal-title":"EMBO Rep"},{"key":"1463_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac199","author":"Z Zou","year":"2022","unstructured":"Zou Z, Ohta T, Miura F, Oki S. Nucleic Acids Res. 2022;50(W1):W175\u201382. https:\/\/doi.org\/10.1093\/nar\/gkac199. ChIP-Atlas 2021 update: a data-mining suite for exploring epigenomic landscapes by fully integrating ChIP-seq, ATAC-seq and Bisulfite-seq data."},{"key":"1463_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae358","author":"Z Zou","year":"2024","unstructured":"Zou Z, Ohta T, Oki S. Nucleic Acids Res. 2024;52(W1):W45\u201353. https:\/\/doi.org\/10.1093\/nar\/gkae358. ChIP-Atlas 3.0: a data-mining suite to explore chromosome architecture together with large-scale regulome data."},{"key":"1463_CR20","doi-asserted-by":"publisher","unstructured":"Chen EY, Tan CM, Kou Y et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics. 2013;14:128. Published 2013 Apr 15. https:\/\/doi.org\/10.1186\/1471-2105-14-128","DOI":"10.1186\/1471-2105-14-128"},{"issue":"W1","key":"1463_CR21","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov MV, Jones MR, Rouillard AD, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44(W1):W90\u20137. https:\/\/doi.org\/10.1093\/nar\/gkw377.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"1463_CR22","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1002\/cpz1.90","volume":"1","author":"Z Xie","year":"2021","unstructured":"Xie Z, Bailey A, Kuleshov MV, et al. Gene Set Knowledge Discovery with Enrichr. Curr Protoc. 2021;1(3):e90. https:\/\/doi.org\/10.1002\/cpz1.90.","journal-title":"Curr Protoc"},{"issue":"1","key":"1463_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13148-019-0742-x","volume":"11","author":"M N\u00f8rgaard","year":"2019","unstructured":"N\u00f8rgaard M, Haldrup C, Bjerre MT, et al. Epigenetic silencing of MEIS2 in prostate cancer recurrence. Clin Epigenetics. 2019;11(1):147. https:\/\/doi.org\/10.1186\/s13148-019-0742-x.","journal-title":"Clin Epigenetics"},{"issue":"4","key":"1463_CR24","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1158\/1535-7163.MCT-22-0583","volume":"22","author":"E Pan","year":"2023","unstructured":"Pan E, Xie W, Ajmera A, et al. A Phase I Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Bone Metastases (COMRADE). Mol Cancer Ther. 2023;22(4):511\u20138. https:\/\/doi.org\/10.1158\/1535-7163.MCT-22-0583.","journal-title":"Mol Cancer Ther"},{"key":"1463_CR25","doi-asserted-by":"publisher","first-page":"5007","DOI":"10.1200\/JCO.2025.43.16_suppl.5007","volume":"43","author":"RR McKay","year":"2025","unstructured":"McKay RR, Xie W, Ajmera A, et al. A multicenter, randomized, phase 2, investigator-initiated ETCTN trial of olaparib\u2009+\u2009radium-223 vs. radium-223 in men with castration-resistant prostate cancer (CRPC) with bone metastases (BM) (COMRADE): Initial efficacy and biomarker analysis. J Clin Oncol. 2025;43:5007. https:\/\/doi.org\/10.1200\/JCO.2025.43.16_suppl.5007.","journal-title":"J Clin Oncol"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-026-01463-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-026-01463-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-026-01463-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T13:02:40Z","timestamp":1786021360000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13550-026-01463-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1463"],"URL":"https:\/\/doi.org\/10.1186\/s13550-026-01463-3","relation":{"references":[{"id-type":"doi","id":"10.1093\/nar\/gkac199","asserted-by":"subject"},{"id-type":"doi","id":"10.1093\/nar\/gkae358","asserted-by":"subject"}]},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"10 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol was approved by the ethics review committee of each participating institution. All participants provided written informed consent. This study does not involve any animal experiments.Informed consent was obtained from all individual participants included in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors affirm that human research participants provided informed consent for publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Masaki Shiota received honoraria from Janssen Pharmaceutical, AstraZeneca, Astellas Pharma, Sanofi, and Bayer and research funding support from Daiichi Sankyo. Tomomi Kamba received honoraria from MSD and Takeda Pharmaceutical. Masatoshi Eto received honoraria from Takeda Pharmaceutical, Janssen Pharmaceutical, AstraZeneca, and Astellas Pharma and research funding support from Astellas Pharma, Sanofi, and Takeda Pharmaceutical.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was registered on the University Hospital Medical Information Network (UMIN) in Japan on May 11, 2020 (protocol ID: UMIN000040358).","order":4,"name":"Ethics","label":"Registry and the registration no. of the study\/trial","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"121"}}